Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Biotech
Boehringer widens fibrosis drug's potential after 2nd ph. 3 win
The German drugmaker didn’t share data behind the result, promising that the efficacy and safety findings would be unveiled in the second quarter.
James Waldron
Feb 10, 2025 10:42am
Novo adds pediatric data to bulging bag of hemophilia A evidence
Feb 7, 2025 5:28am
Denali rare disease drug clears safety study, reduces biomarkers
Feb 6, 2025 12:05pm
Kura, Kyowa hail ph. 2 win for leukemia drug, but hold back data
Feb 6, 2025 10:40am
Qlaris sees double as drug reduces eye pressure in ph. 2 trials
Feb 5, 2025 9:53am
Novo fails trial, linking obesity asset to psychiatric effects
Feb 5, 2025 7:39am